Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction

EBioMedicine

Volumn 4, Issue , 2016, Pages 86-94

  Berezin, Alexander E ^a   Kremzer, Alexander A ^a   Martovitskaya, Yulia V ^b   Berezina, Tatyana A ^c   Gromenko, Elena A ^d  

^a ZAPORIZHZHIA STATE MEDICAL UNIVERSITY   (Ukraine)

^b Clinical Laboratory Dia Service   (Ukraine)

^c Private Center Vita Center   (Ukraine)

^d Pathology Bureau   (Ukraine)

Author keywords

Biomarkers; Chronic heart failure; Endothelial cell derived microvesicles; Endothelial progenitor cells; Preserved left ventricular function

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOPOIETIN RECEPTOR; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD14 ANTIGEN; CD309 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; GALECTIN 3; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOCORTIN 5; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYMPHOCYTE ANTIGEN; PADGEM PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRIC PARAMETERS; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONTROLLED STUDY; ENDOTHELIAL MICROPARTICLE; ENDOTHELIAL PROGENITOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GLOMERULUS FILTRATION RATE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; TISSUE DOPPLER IMAGING; TRANSTHORACIC ECHOCARDIOGRAPHY; ANGIOGENESIS; BLOOD; CASE CONTROL STUDY; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MEMBRANE MICROPARTICLE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; APOPTOSIS; BIOMARKERS; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; ENDOTHELIAL PROGENITOR CELLS; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84956465373     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.01.018     Document Type: Article

References (46)

1. António, N., Soares, A., Carvalheiro, T., Fernandes, R., Paiva, A., Ventura, M., et al. Circulating endothelial progenitor cells as a predictor of response to cardiac resynchronization therapy: the missing piece of the puzzle?. Pacing Clin. Electrophysiol. 37:6 (2014), 731–739.
2. Awad, O., Dedkov, E.I., Jiao, C., Bloomer, S., Tomanek, R.J., Schatteman, G.C., Differential healing activities of CD34 + and CD14 + endothelial cell progenitors. Arterioscler. Thromb. Vasc. Biol. 26:4 (2006), 758–764.
3. Bank, I.E., Timmers, L., Gijsberts, C.M., Zhang, Y.N., Mosterd, A., Wang, J.W., et al. The diagnostic and prognostic potential of plasma extracellular vesicles for cardiovascular disease. Expert. Rev. Mol. Diagn., 1-12, 2015.
4. Berezin, A.E., Endothelial derived micro particles: biomarkers for heart failure diagnosis and management. J. Clin. Trial Cardiol. 2:3 (2015), 1–3.
5. Berezin, A.E., Impaired phenotype of circulating endothelial-derived microparticles: novel marker of cardiovascular risk. J. Cardiol. Ther. 2:4 (2015), 273–278, 10.17554/j.issn.2309–6861.2015.02.77.
6. Berezin, A.E., Kremzer, A.A., Impaired phenotype of circulating endothelial microparticles in chronic heart failure patients: relevance to body mass index. Diabetol. Metab. Syndr. 9:4 (2015), 230–236, 10.1016/j.dsx.2015.04.003.
7. Berezin, A.E., Kremzer, A.A., Content of circulating endothelial progenitor cells in patients with chronic ischemic heart failure with preserved left ventricular ejection fraction. Kardiologiia 55:1 (2015), 14–22.
8. Berezin, A.E., Kremzer, A.A., Samura, T.A., Berezina, T.A., Kruzliak, P., Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus. J. Endocrinol. Investig. 38:8 (2015), 865–874, 10.1007/s40618-015-0273-z.
9. Berezin, A.E., Kremzer, A.A., Samura, T.A., Martovitskaya, Y.V., Malinovskiy, Y.V., Oleshko, S.V., et al. Predictive value of apoptotic microparticles to mononuclear progenitor cells ratio in advanced chronic heart failure patients. J. Cardiol. 65 (2015), 403–411.
10. Berezin, A., Zulli, A., Kerrigan, S., Petrovic, D., Kruzliak, P., Predictive role of circulating endothelial-derived microparticles in cardiovascular diseases. Clin. Biochem. 48:9 (2015), 562–568, 10.1016/j.clinbiochem.2015.02.003.
11. Burger, D., Touyz, R.M., Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells and circulating endothelial cells. J. Am. Soc. Hypertens. 6 (2012), 85–99.
12. Chamberlain, A.M., St Sauver, J.L., Gerber, Y., Manemann, S.M., Boyd, C.M., Dunlay, S.M., et al. Multimorbidity in heart failure: a community perspective. Am. J. Med. 128:1 (2015), 38–45.
13. D'Elia, E., Vaduganathan, M., Gori, M., Gavazzi, A., Butler, J., Senni, M., Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use. Eur. J. Heart Fail., 2015, 10.1002/ejhf.430 (Epub ahead of print).
14. Dignat-George, F., Boulanger, C.M., The many faces of endothelial microparticles. Arterioscler. Thromb. Vasc. Biol. 31 (2011), 27–33.
15. Dunlay, S.M., Manemann, S.M., Chamberlain, A.M., Cheville, A.L., Jiang, R., Weston, S.A., et al. Activities of daily living and outcomes in heart failure. Circ. Heart Fail. 8:2 (2015), 261–267.
16. Executive summary, Standards of medical care in diabetes — 2013. Diabetes Care 36:1 (2013), S4–10.
17. Friões, F., Lourenço, P., Laszczynska, O., Almeida, P.B., Guimarães, J.T., Januzzi, J.L., et al. Prognostic value of sST2 added to BNP in acute heart failure with preserved or reduced ejection fraction. Clin. Res. Cardiol. 104:6 (2015), 491–499.
18. Fujisue, K., Sugiyama, S., Matsuzawa, Y., Akiyama, E., Sugamura, K., Matsubara, J., et al. Prognostic significance of peripheral microvascular endothelial dysfunction in heart failure with reduced left ventricular ejection fraction. Circ. J. 79:12 (2015), 2623–2631.
19. Gerber, Y., Weston, S.A., Redfield, M.M., Chamberlain, A.M., Manemann, S.M., Jiang, R., et al. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern. Med. 175:6 (2015), 996–1004.
20. Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Blaha, M.J., et al. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation 129:3 (2014), e28–e292.
21. Hoffman, R.A., Standardization, calibration, and control in flow cytometry. Curr. Protoc. Cytom., 2005, 10.1002/0471142956.cy0103s32 (chapter 1: unit 1.3).
22. Huang, P.H., Huang, S.S., Chen, Y.H., Lin, C.P., Chiang, K.H., Chen, J.S., et al. Increased circulating CD31 +/annexin V + apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria. J. Hypertens. 28:8 (2010), 1655–1665.
23. Jorge, A.L., Rosa, M.L., Martins, W.A., Correia, D.M., Fernandes, L.C., Costa, J.A., et al. the prevalence of stages of heart failure in primary care: a population-based study. J. Card. Fail., 2015, 10.1016/j.cardfail.2015.10.017 (Epub ahead of print).
24. Kaila, K., Haykowsky, M.J., Thompson, R.B., Paterson, D.I., Heart failure with preserved ejection fraction in the elderly: scope of the problem. Heart Fail. Rev. 17:4–5 (2012), 555–562, 10.1007/s10741-011-9273-z.
25. Kang, S.H., Park, J.J., Choi, D.J., Yoon, C.H., Oh, I.Y., Kang, S.M., et al. Registry. prognostic value of NT-proBNP in heart failure with preserved versus reduced EF. Heart 101:23 (2015), 1881–1888.
26. Koller, L., Kleber, M., Goliasch, G., Sulzgruber, P., Scharnagl, H., Silbernagel, G., et al. C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction. Eur. J. Heart Fail. 16:7 (2014), 758–766.
27. Lacroix, R., Judicone, C., Mooberry, M., Boucekine, M., Key, N.S., Dignat-George, F., The ISTH SSC Workshop. Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC collaborative workshop. J. Thromb. Haemost., 2013, 10.1111/jth.12207 (Epub ahead of print).
28. Lacroix, R., Robert, S., Poncelet, P., Dignat-George, F., Overcoming limitations of microparticle measurement by flow cytometry. Semin. Thromb. Hemost. 36 (2010), 807–818.
29. Levey, A.S., Stevens, L.A., Schmid, C.H., et al. For the CKD-EPI (chronic kidney disease epidemiology collaboration). A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150 (2009), 604–612.
30. McMurray, J.J., Adamopoulos, S., Anker, S.D., Auricchio, A., Bohm, M., Dickstein, K., et al. ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail. 14:8 (2012), 803–869.
31. Michelucci, A., Cesari, F., Ricciardi, G., Attanà, P., Pieragnoli, P., Ristalli, F., et al. Left ventricular mass and progenitor cells in chronic heart failure patients. Intern. Emerg. Med. 10:3 (2015), 329–335.
32. Montoro-García, S., Shantsila, E., Wrigley, B.J., Tapp, L.D., Abellán Alemán, J., Lip, G.Y., Small-size microparticles as indicators of acute decompensated state in ischemic heart failure. Rev. Esp. Cardiol. (Engl. Ed.) 68:11 (2015), 951–958.
33. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, (Adult Treatment Panel III) third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:25 (2002), 3143–3421.
34. Orozco, A.F., Lewis, D.E., Flow cytometric analysis of circulating microparticles in plasma. Cytometry 77:6 (2010), 502–514.
35. Paulus, W.J., Tschöpe, C., Sanderson, J.E., Rusconi, C., Flachskampf, F.A., Rademakers, F.E., et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur. Heart J. 28:20 (2007), 2539–2550.
36. Quiñones, M.A., Douglas, P.S., Foster, E., Gorcsan, J.I.I.I., Lewis, J.F., Pearlman, A.S., et al., American College of Cardiology, American Heart Association, American College of Physicians, American Society of Internal Medicine Task Force on Clinical Competence, American College of Cardiology/American Heart Association clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians — American Society of Internal Medicine Task Force on Clinical Competence. Circulation 107:7 (2003), 1068–1089.
37. Sanders-van Wijk, S., van Empel, V., Davarzani, N., Maeder, M.T., Handschin, R., Pfisterer, M.E., et al; TIME-CHF Investigators. Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction. Eur. J. Heart Fail. 17:10 (2015), 1006–1014.
38. Sandri, M., Viehmann, M., Adams, V., Rabald, K., Mangner, N., Höllriegel, R., et al. Chronic heart failure and aging — effects of exercise training on endothelial function and mechanisms of endothelial regeneration: results from the Leipzig exercise intervention in chronic heart failure and aging (LEICA) study. Eur. J. Prev. Cardiol., 2015 (pii: 2047487315588391. [Epub ahead of print]).
39. Sansone, R., Stanske, B., Keymel, S., Schuler, D., Horn, P., Saeed, D., et al. Macrovascular and microvascular function after implantation of left ventricular assist devices in end-stage heart failure: role of microparticles. J. Heart Lung Transplant. 34:7 (2015), 921–932.
40. Sen, S., McDonald, S.P., Coates, P.T., Bonder, C.S., Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. Clin. Sci. (Lond.) 120:7 (2011), 263–283.
41. Shah, M.D., Bergeron, A.L., Dong, J.F., Lopez, J.A., Flow cytometric measurement of microparticles: pitfalls and protocol modifications. Platelets 19 (2008), 365–372.
42. Singh, N., Van Craeyveld, E., Tjwa, M., Ciarka, A., Emmerechts, J., Droogne, W., et al. Circulating apoptotic endothelial cells and apoptotic endothelial microparticles independently predict the presence of cardiac allograft vasculopathy. J. Am. Coll. Cardiol. 60 (2012), 324–331.
43. Sinning, J.M., Losch, J., Walenta, K., Böhm, M., Nickenig, G., Werner, N., Circulating CD31 +/annexin V + microparticles correlate with cardiovascular outcomes. Eur. Heart J. 32:16 (2011), 2034–2041.
44. Tung, J.W., Parks, D.R., Moore, W.A., et al. New approaches to fluorescence compensation and visualization of FACS Data. Clin. Immunol. 110 (2004), 277–283.
45. Werner, N., Wassmann, S., Ahlers, P., Kosiol, S., Nickenig, G., Circulating CD31 +/annexin V + apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 26:1 (2006), 112–116.
46. Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey, D.E. Jr., Drazner, M.H., et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 62:16 (2013), e147–e239.